- Home
- RENE vs CATX Comparison
RENE vs CATX Comparison
Compare RENE & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENE
- CATX
- Stock Information
- Founded
- RENE 2021
- CATX 1983
- Country
- RENE United States
- CATX United States
- Employees
- RENE N/A
- CATX N/A
- Industry
- RENE Blank Checks
- CATX Medical/Dental Instruments
- Sector
- RENE Finance
- CATX Health Care
- Exchange
- RENE Nasdaq
- CATX Nasdaq
- Market Cap
- RENE 153.8M
- CATX 183.2M
- IPO Year
- RENE 2022
- CATX N/A
- Fundamental
- Price
- RENE $11.83
- CATX $2.17
- Analyst Decision
- RENE
- CATX Strong Buy
- Analyst Count
- RENE 0
- CATX 11
- Target Price
- RENE N/A
- CATX $15.30
- AVG Volume (30 Days)
- RENE 6.1K
- CATX 562.0K
- Earning Date
- RENE 01-01-0001
- CATX 03-26-2025
- Dividend Yield
- RENE N/A
- CATX N/A
- EPS Growth
- RENE 42.91
- CATX N/A
- EPS
- RENE 0.43
- CATX N/A
- Revenue
- RENE N/A
- CATX $1,454,000.00
- Revenue This Year
- RENE N/A
- CATX N/A
- Revenue Next Year
- RENE N/A
- CATX $1.15
- P/E Ratio
- RENE $27.36
- CATX N/A
- Revenue Growth
- RENE N/A
- CATX 1.40
- 52 Week Low
- RENE $11.10
- CATX $2.19
- 52 Week High
- RENE $11.86
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- RENE 72.13
- CATX 29.35
- Support Level
- RENE $11.77
- CATX $2.32
- Resistance Level
- RENE $11.78
- CATX $2.62
- Average True Range (ATR)
- RENE 0.00
- CATX 0.19
- MACD
- RENE 0.00
- CATX -0.02
- Stochastic Oscillator
- RENE 100.00
- CATX 2.59
About RENE Cartesian Growth Corporation II
Cartesian Growth Corp II is a blank check company.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.